Medical treatment of patients with heart failure or left ventricular dysfunction undergoing percutaneous coronary

Michael J Lipinski1, George W Vetrovec

  • 1Division of Cardiology, Medical College of Virginia Campus of Virginia Commonwealth University, Richmond, Virginia, USA.

Insights

This review outlines a management strategy for ischemic heart patients with left ventricular (LV) dysfunction, focusing on percutaneous coronary intervention (PCI) timing and optimal medications to improve outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Heart Failure Management

Background:

  • Ischemic patients with left ventricular (LV) dysfunction present complex management challenges.
  • Optimizing outcomes while minimizing risk requires careful consideration of percutaneous coronary intervention (PCI) timing and adjunctive medications.

Purpose of the Study:

  • To provide a systematic management scheme for patients with heart failure or LV dysfunction presenting with various ischemic syndromes.
  • To offer evidence-based recommendations for medication use before, during, and after PCI.

Main Methods:

  • Systematic review of therapeutic approaches for acute or decompensated heart failure.
  • Analysis of coronary angiography timing based on ischemia severity.
  • Evidence-based recommendations for pharmacotherapy in PCI management.

Main Results:

  • A structured approach to managing ischemic heart failure patients undergoing PCI.
  • Guidance on selecting appropriate adjunctive medications to enhance treatment efficacy.
  • Recommendations for timing of invasive procedures based on clinical presentation and ischemic burden.

Conclusions:

  • A comprehensive management strategy is crucial for ischemic patients with LV dysfunction undergoing PCI.
  • Tailored pharmacotherapy and procedural timing can significantly improve patient outcomes.
  • This review provides a framework for evidence-based decision-making in complex cardiovascular cases.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...